Search

Your search keyword '"Biological products industry -- Research -- Reports"' showing total 446 results

Search Constraints

Start Over You searched for: Descriptor "Biological products industry -- Research -- Reports" Remove constraint Descriptor: "Biological products industry -- Research -- Reports"
446 results on '"Biological products industry -- Research -- Reports"'

Search Results

1. New Antibodies Study Findings Have Been Reported by Investigators at Genentech Inc. (A Generic Anti-drug Antibody Assay for Monoclonal Antibody Therapeutics With Broad Dynamic Range Eliminates the Need for Titer Evaluation In Preclinical Studies)

2. Researchers from Gilead Sciences Inc. Provide Details of New Studies and Findings in the Area of Drugs and Therapies (Delta Inflation, Optimism Bias, and Uncertainty In Clinical Trials)

3. Researchers from Biogen Inc. Report on Findings in Parkinson's Disease (RIT2 regulates autophagy lysosomal pathway induction and protects against a-synuclein pathology in a cellular model of Parkinson's disease)

4. Studies from Fundacion Jimenez Diaz University Hospital Have Provided New Data on Chemotherapy (The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain)

5. Reports Outline Breast Cancer Study Results from IRCCS Humanitas Research Hospital [Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective ...]

6. Recent Findings in Biotechnology Described by Researchers from Genentech Inc. (Analysis of Non-mutagenic Substances In the Context of Drug Impurity Assessment - Few Are Potent Toxicants)

7. Researcher at Neurology Department Targets Spinal Muscular Atrophy (Nusinersen Treatment for Spinal Muscular Atrophy: Retrospective Multicenter Study of Pediatric and Adult Patients in Kuwait)

8. Research from Genentech Inc. in Antibiotics Provides New Insights (Potent activity of polymyxin B is associated with long-lived super-stoichiometric accumulation mediated by weak-affinity binding to lipid A)

9. Studies from Biogen Inc. Have Provided New Data on Biotechnology (A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of Cns-penetrant Aza-indazole Irak4 Inhibitors)

10. New Data from Genentech Inc. Illuminate Findings in Pharmacometrics and Systems Pharmacology (Population Pharmacokinetics and Exposure-response Analyses of Polatuzumab Vedotin In Patients With Previously Untreated Dlbcl From the Polarix Study)

11. Studies from Genentech Inc. Yield New Information about Biotechnology (Clinical Pharmacology Strategies To Accelerate the Development of Polatuzumab Vedotin and Summary of Key Findings)

12. New Ulcerative Colitis Findings from Genentech Inc. Outlined (Il-22 Alters Gut Microbiota Composition and Function To Increase Aryl Hydrocarbon Receptor Activity In Mice and Humans)

13. New Biotechnology Findings Has Been Reported by Investigators at Genentech Inc. (Delivering On the Promise of Protein Degraders)

14. Biogen Inc. Researchers Publish Findings in Biotechnology (Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice)

15. Recent Findings in Colon Cancer Described by Researchers from Genentech Inc. (Enrichment of Oral-derived Bacteria In Inflamed Colorectal Tumors and Distinct Associations Of Fusobacterium In the Mesenchymal Subtype)

16. Findings on Hypothyroidism Discussed by Investigators at Genentech Inc. (Notch Signaling In Thyrocytes Is Essential for Adult Thyroid Function and Mammalian Homeostasis)

17. Genentech Inc. Researcher Details New Studies and Findings in the Area of Nanoparticles (Utilizing Molecular Simulations to Examine Nanosuspension Stability)

18. Investigators at Genentech Inc. Report Findings in Cytokines [Assessment of Cyp3a-mediated Drug Interaction Via Cytokine (Il-6) Elevation for Mosunetuzumab Using Physiologically-based Pharmacokinetic Modeling]

19. Research from University of Colorado Reveals New Findings on Viral Load (Modern antiretroviral regimens in pregnant women: virologic outcomes and durability)

20. New Findings from Genentech Inc. Describe Advances in Biotechnology [Population Pharmacokinetics and Pharmacodynamics of Efmarodocokin Alfa (Il-22fc)]

21. Studies in the Area of Drug Resistance Reported from Gilead Sciences Inc. [Us Cost-utility Model of Lenacapavir Plus Optimized Background Regimen (Obr) Vs Fostemsavir Plus Obr and Ibalizumab Plus Obr for People With Hiv With Multidrug Resistance]

22. Studies from Gilead Sciences Inc. Reveal New Findings on HIV/AIDS [High Efficacy of Bictegravir/emtricitabine/tenofovir Alafenamide (B/f/taf) In Black Adults In the United States, Including Those With Pre-existing Hiv Resistance and Suboptimal ...]

23. Data on HIV/AIDS Discussed by Researchers at Gilead Sciences Inc. (Bictegravir/emtricitabine/tenofovir Alafenamide In Adults With Hiv-1 and End-stage Kidney Disease On Chronic Haemodialysis)

24. New Research on COVID-19 from Centro Hospitalar e Universitario de Coimbra Summarized (Long COVID in Immunocompromised and Immunocompetent Patients: A Clinical, Morphologic, and Virologic Portrait)

25. Report Summarizes Science Study Findings from Genentech Inc. (The discovery and structural basis of two distinct state-dependent inhibitors of BamA)

26. Investigators at Gilead Sciences Inc. Detail Findings in Biotechnology (Temperature Excursion Management: a Tier-based Approach for Commercial Oral Solid Dosage Forms)

27. Studies in the Area of Immunoglobulins Reported from Genentech Inc. (Rapid affinity optimization of an anti-TREM2 clinical lead antibody by cross-lineage immune repertoire mining)

28. New Non-Hodgkin Lymphoma Findings from Genentech Inc. Described (Automated Lugano Metabolic Response Assessment In 18f-fluorodeoxyglucose-avid Non-hodgkin Lymphoma With Deep Learning On 18f-fluorodeoxyglucose

29. Yekatit 12 Hospital Medical College Researchers Yield New Study Findings on HIV/AIDS (Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia)

30. Study Findings on Vaccines Are Outlined in Reports from Purdue University (Exploring the feasibility and acceptability of community paramedicine programs in achieving vaccination equity: a qualitative study)

31. New Findings in Biotechnology Described from Genentech Inc. (Identification of a Discrete Diglucuronide of Gdc-0810 In Human Plasma After Oral Administration)

32. Researchers from Gilead Sciences Inc. Publish New Studies and Findings in the Area of Gastroenterology (Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV)

33. Research from Gilead Sciences Inc. Has Provided New Study Findings on Inflammatory Bowel Disease (Janus kinase inhibitors differentially inhibit specific cytokine signals in the mesenteric lymph node cells of IBD patients)

34. New Cell Therapy Findings from Genentech Inc. Described (Clinical Pharmacology Perspectives for Adoptive Cell Therapies In Oncology)

35. Academy of Athens Researchers Release New Study Findings on Neuroblastomas (* * MYCN* * Amplifications and Metabolic Rewiring in Neuroblastoma)

36. New Findings from Genentech Inc. in the Area of Biomarkers Described (MOSBY enables multi-omic inference and spatial biomarker discovery from whole slide images)

37. New Findings from Genentech Inc. in the Area of Biotechnology Reported (Tactics and Strategies for the Synthesis of Cereblon Ligands)

38. Genentech Inc. Researchers Yield New Study Findings on Urticaria (Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?)

39. Reports Outline Pharmaceutics Study Findings from Rentschler Biopharma SE [Development of a Clonal and High-Yield Mammalian Cell Line for the Manufacturing of a Hyperactive Human DNase I with Extended Plasma Half-Life Using PASylation[superscript]®

40. Study Findings on Remdesivir Reported by a Researcher at Massachusetts General Hospital (Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial)

41. Researcher from Kyung Hee University School of Medicine Reports on Findings in Chronic Hepatitis C Virus (Prognosis Following Sustained Virologic Response in Korean Chronic Hepatitis C Patients Treated with Sofosbuvir-Based Treatment: Data from ...)

42. New Findings in Biotechnology Described from Genentech Inc. (Streamlined Synthesis of Shp2 Inhibitor Gdc-1971 Enhanced By a Telescoped Schotten-baumann Snar and Reactive Crystallization Cascade)

43. New Biotechnology Findings from Gilead Sciences Inc. Reported (Accelerated and Biopredictive In Vitro Release Testing Strategy for Single Agent and Combination Long-acting Injectables)

44. New Arenavirus Study Findings Reported from Gilead Sciences Inc. (Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates)

45. Data on HIV/AIDS Reported by Researchers at Emory University (Depression: an individual-level early warning indicator of virologic failure in HIV patients in South Africa)

46. Research from University of Rochester Medical Center Yields New Data on Parkinson's Disease (Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months)

47. Findings from University of Colorado Has Provided New Data on Cytomegalovirus (Cytomegalovirus Igg Is Associated With Physical Function but Not Muscle Density In People With Hiv)

48. Researchers' Work from Chulalongkorn University Focuses on COVID-19 (Silk Fibroin-based Hydrogel As Injectable Carrier for Prolonged Immunization of Plant-based Covid-19 Subunit Vaccine)

49. New Myelodysplastic Syndromes Findings from Gilead Sciences Inc. Described (Real-world Effectiveness of Azacitidine In Treatment-naive Patients With Higher-risk Myelodysplastic Syndromes)

50. New Multiple Myeloma Findings from University of California Davis Reported (Utilization of Autologous Hematopoietic Cell Transplantation Over Time In Multiple Myeloma: a Population-based Study)

Catalog

Books, media, physical & digital resources